IB Acquisition Corp. (NASDAQ:IBACU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “IBACU”, Tuesday, March 26, 2024.
The new SPAC will have a broad search focus and will not be limited to a particular geographic region or industry, but believe there are compelling investment opportunities in a number of areas including fintech, healthcare and life sciences, sports and entertainment, and consumer goods.
IB Acquisition Corp’s sponsor team will be led by Adelmo “Al” Lopez, as Chairman and Chief Executive Officer, with Christy Albeck serving as Chief Financial Officer, and John Joyce as Vice Chairman. Silvia Panigone and Jian Zhang serve as Directors.
Total SPAC deal count for 2024 year-to-date is now 6. This offering is expected to close on Thursday, March 28, 2024.
I-Bankers Securities, Inc. and IB Capital LLC are acting as joint book-running managers of the offering. ArentFox Schiff LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. UHY LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...
At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...
Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...
Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...
Churchill Capital Corp IX (NASDAQ:CCIXU) announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCIXU”, Thursday, May 2, 2024. The new SPAC will conduct a broad search and has not limited itself to any particular sector or focus, but it plans to...